Guides for women on GLP-1 medicines
Short, sourced answers to the questions women ask most on Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1s. Every medical number links to the FDA prescribing information or the original study.
- GLP-1s and your menstrual cycle: what's known and how to track itWhat research says about appetite and digestion across the menstrual cycle, what it does and doesn't tell us about Ozempic, Wegovy, Mounjaro and Zepbound, and how to track your own pattern.
- Mounjaro, Zepbound and birth control pills: the 4-week ruleTirzepatide can make birth control pills less effective. The labels advise a non-oral method or a backup for 4 weeks after starting and after each dose increase; Foundayo says 30 days.
- Missed a GLP-1 dose? What the labels say for Ozempic, Wegovy, Mounjaro and ZepboundThe missed-dose rules from each prescribing label: Ozempic within 5 days, Mounjaro and Zepbound within 4 days, and Wegovy's newer 2-days-to-next-dose rule.
- GLP-1 half-life: how long semaglutide and tirzepatide stay in your bodyHalf-lives from the FDA labels: semaglutide about 1 week, tirzepatide about 5 days, dulaglutide about 5 days, liraglutide about 13 hours, orforglipron 29–49 hours.
- GLP-1 injection sites: where to inject and how to rotateWhere each label says to inject Ozempic, Wegovy, Mounjaro and Zepbound, why rotation matters, and a simple rotation plan you can follow every week.
- How much protein do you need on a GLP-1?The 2025 joint nutrition advisory suggests 1.2–1.6 g of protein per kg of body weight a day (or 80–120 g) during GLP-1 weight loss. A table by body weight and tips for low-appetite days.
- GLP-1 side effects: how common they are and how to track themNausea, diarrhea, vomiting and constipation rates from the Wegovy and Zepbound labels, when they tend to happen, and what to log so you can talk to your doctor.